Clinical Trials Browser

Completed × Papillomavirus Vaccines × Clear all

Papillomavirus Infections

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Condylomata Acuminata, Papillomavirus Infections

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

HIV Infections

Anus Neoplasms, Uterine Cervical Neoplasms, Head and Neck Neoplasms

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms, Condylomata Acuminata, Papillomavirus Infections

Anus Neoplasms, Uterine Cervical Neoplasms, Condylomata Acuminata, Vulvar Neoplasms, Papillomavirus Infections

Anus Neoplasms, Uterine Cervical Neoplasms, Condylomata Acuminata, Vaginal Neoplasms, Vulvar Neoplasms, Papillomavirus Infections

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

Persistent Infection, Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

Papillomavirus Infections

Papillomavirus Infections

Uterine Cervical Neoplasms, Virus Diseases, Papillomavirus Infections

Uterine Cervical Neoplasms, Papillomavirus Infections

Uterine Cervical Neoplasms, Papillomavirus Infections

Papillomavirus Infections

Uterine Cervical Neoplasms, Papillomavirus Infections

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Papillomavirus Infections

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

Uterine Cervical Neoplasms, Condylomata Acuminata

Uterine Cervical Neoplasms, Condylomata Acuminata

Diphtheria, Meningitis, Neoplasms, Glandular and Epithelial, Tetanus, Whooping Cough

Uterine Cervical Dysplasia, Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases

Clinical Trials

TRAP-HPV

Impact of HPV Vaccination Against Cervical Lesions and Genital Warts in Colombia. an Ecological Assessment

Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 Study

ERADICATING CERVICAL CANCER IN KENYA

Trial To Test Safety And Efficacy Of Vaccination For Incurable HPV 16-Related Oropharyngeal, Cervical And Anal Cancer

Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 Vaccine in Healthy Females

A Study of Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine

A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine

A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccine

Randomized, Double Blind Trial of the Quadrivalent HPV Vaccine to Improve Responses to LEEP Treatment of Cervical HSIL

Efficacy and Immunogenicity Study of Recombinant Human Papillomavirus Bivalent（Type 16/18 ）Vaccine

Human Papilloma Virus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Bio's Novel HPV Vaccine.

Evaluation of the Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV Vaccine in Young Males.

Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bio's HPV Vaccine 580299 in Healthy Women Aged 9-25 Yrs

Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus Vaccine With Another Vaccine in Healthy Female Subjects

Evaluation of Immunogenicity and Safety of Human Papillomavirus (HPV) Vaccine Co-administered With Another Vaccine in Healthy Female Subjects

V503-010

Immunogenicity and Safety of GlaxoSmithKline Biologicals' Huma Papillomavirus (HPV) Vaccine 580299 in Healthy Females 15 - 25 Years of Age

Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung Cancer

An Immunogenicity and Safety Study of Gardasil® in Chinese Subjects (V501-030)(COMPLETED)

Dose-Ranging Study of Recombinant Human Papillomavirus Virus 16/18 Bivalent Vaccine

Cervical Intraepithelial Neoplasm (CIN)-Warts Efficacy Trial in Women (Gardasil)(V501-013)(COMPLETED)

BCGov-01

Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025)

Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease